Here are five facts:
1. Dr. Cobbs has been a Nativis scientific and medical advisory board member since 2015.
2. He is the Gregory Foltz, M.D. Endowed Director/Neurosurgeon of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute.
3. He earned his medical degree from the University of Alabama School of Medicine in Birmingham.
4. Dr. Cobbs completed his neurosurgical residency and neuro-oncology fellowship at the University of California, San Francisco.
5. Nativis is a clinical-stage bio-electronics company based in Seattle.
More device news:
Zimmer Biomet to present clinical data on Aspen MIS Fusion System & Timberline Systems at CNS meeting: 5 highlights
AxioMed receives Australian market approval for Freedom Viscoelastic Disc Replacement technology: 5 points
Blue Cross Blue Shield of Nebraska to cover minimally invasive sacroiliac joint fusion: 3 takeaways
